Possible anxiolytic effects of ivermectin in rats

Veterinary Research Communications

Volumn 26, Issue 4, 2002, Pages 309-321

  de Souza Spinosa, H ^a   Stilck, S R A N ^a   Bernardi, M M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anxiety; Avermectin; Behaviour; Central nervous system; Convulsion; Diazepam; GABA; Ivermectin; Pentylenetetrazole; Picrotoxin; Rat; Seizure

Indexed keywords

ANTIPARASITIC AGENT; ANXIOLYTIC AGENT; AVERMECTIN DERIVATIVE; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; DIENPAX; DORAMECTIN; IVERMECTIN; MACROCYCLIC COMPOUND; PENTETRAZOLE; PICROTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; CENTRAL NERVOUS SYSTEM; CONFLICT; CONTROLLED STUDY; CONVULSION; DRUG INDUCED DISEASE; FREQUENCY ANALYSIS; GABAERGIC TRANSMISSION; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; OPEN FIELD BEHAVIOR; RAT; REARING; REVERSAL REACTION; SEDATION; SEIZURE; SHOCK; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; ANXIETY; BEHAVIOR, ANIMAL; DIAZEPAM; IVERMECTIN; LOCOMOTION; MALE; PICROTOXIN; RATS; RATS, WISTAR; SEIZURES;

ANIMALIA; STREPTOMYCES; UNCULTURED ACTINOMYCETE;

EID: 0036334480     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016094726033     Document Type: Article

References (51)

1. A patch clamp study of a glutamatergic chloride channel on pharyngeal muscle of the nematode Ascaris suum
2. Anticonvulsant effects of avermectin in DBA/2 mice and rat
3. Tests of emotionality in rats and mice: A review
4. Expression of Caenorhabditis elegans messenger RNA in Xenopus-oocytes: A model system to study the mechanisms of action of avermectins
5. Drugs and the treatment of psychiatric disorders: Psychosis and anxiety
6. Impact of differential housing on humoral immunity following exposure to an acute stressor in rats
7. Behavioral techniques in preclinical neuropsychopharmacology research
8. The effects of GABAergic drugs on grooming behavior in open-field
9. Fear and fearfulness in animals
10. A sensitive open field measure of anxiolytic drug activity
11. Experiments in psychogenetics
12. Effect of 5-HT1A agonists on stress-induced deficit in open field locomotor activity of rats: Evidence that this model identifies anxiolytic-like activity
13. Anxiogenic and non-anxiogenic benzodiazepine antagonists
14. Metabolism and tissue residues
15. Inhibitory glutamate receptor channels
16. Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze
17. Ethopharmacological analysis of rat behaviour on the elevated plus-maze
18. Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans
19. Identification of a Drosophila melanogaster glutamate-gated chloride channel sensitive to the antiparasitic agent ivermectin
20. Individual housing from rearing modifies the performance of young rats on the elevated plus-maze apparatus
21. GABAergic influences on plus-maze behaviour in mice
22. Use of conditioned taste aversion as a conflict model: Effects of anxiolytic drugs
23. Modification of chlordiazepoxide's behavioural and neurochemical effects of handling and plus-maze experience
24. Raised corticosterone in the rat after exposure to the elevated plus-maze
25. Aversive and compensatory classical conditioning with diazepam as conditional stimulus
26. The effects of mebrobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the rat
27. Effect of diazepam, apomorphine and haloperidol on the audiogenic immobility reaction and on the open field behavior
28. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety
29. Neurotransmitters
30. Animal models of drug addition
31. The use of a plus-maze to measure anxiety in the mouse
32. Ivermectin and piperazine toxicoses in dogs and cats
33. Target sites of anthelmintics
34. 1a
35. The relation between fear induced by novel stimulation and exploratory behaviour
36. Comparison of the effects of buspirone and chlordiazepoxide on successive discrimination
37. GABA and glycine
38. Multiple sites of action for anxiogenic drugs: Behavioural, electrophysiological and biochemical correlations
39. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat
40. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
41. 1a: Stimulation and release of gamma-aminobutyric acid from brain synaptosomes
42. The elevated plus-maze: Pharmacology, methodology and ethology
43. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety
44. Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience
45. Animal models of anxiety: An ethological perspective
46. Anxiety
47. Anxiolytic and anticonvulsant properties of doramectin in rats: Behavioral and neurochemistric evaluations
48. Mode of action of ivermectin
49. Evolutionary relationship of ligand-gated ion channels and the avermectin-sensitive, glutamate-gated chloride channels
50. The open-field test: A critical review
51. Abuse and therapeutic use of benzodiazepines and benzodiazepine-like drugs